COMT Val158Met moderation of cannabis‐induced psychosis: a momentary assessment study of ‘switching on’ hallucinations in the flow of daily life

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Acta Psychiatrica Scandinavica

• Publication date

  2009-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/j.1600-0447.2008.01265.xPMID 18808401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence that the COMTVal158Met polymorphism moderates sensitivity to stress in psychosis: An experience‐sampling study

  2008cited by this paper
• Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use

  2007cited by this paper
• An Experimental Study of Catechol-O-Methyltransferase Val158Met Moderation of Δ-9-Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition

  2006cited by this paper
• Electronic monitoring of salivary cortisol sampling compliance in daily life.

  2005cited by this paper
• The environment and schizophrenia: the role of cannabis use.

  2005cited by this paper
• Subtle fluctuations in psychotic phenomena as functional states of abnormal dopamine reactivity in individuals at risk.

  2005cited by this paper
• The incidence and outcome of subclinical psychotic experiences in the general population.

  2005cited by this paper
• Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.

  2005cited by this paper
• The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes

  2004cited by this paper
• New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis.

  2004cited by this paper
• Hallucinatory experiences and onset of psychotic disorder: evidence that the risk is mediated by delusion formation

  2004cited by this paper
• Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study

  2003cited by this paper
• Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia.

  2003cited by this paper
• Are cognitive impairments associated with sensitivity to stress in schizophrenia? An experience sampling study.

  2002cited by this paper
• Emotional reactivity to daily life stress in psychosis.

  2001cited by this paper
• Cannabis induced dopamine release: an in-vivo SPECT study.

  2001cited by this paper
• The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving.

  2000cited by this paper
• The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies.

  2000cited by this paper
• Assessing Schizophrenia in Daily Life: The Experience Sampling Method.

  1996cited by this paper
• No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity.

  1996cited by this paper
• Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

  1996cited by this paper
• Assessing Schizophrenia in Daily Life: The Experience Sampling Method

  1995cited by this paper
• The self, attributional processes and abnormal beliefs: towards a model of persecutory delusions.

  1994cited by this paper

• Clinical Epigenomic Explanation of the Epidemiology of Cannabinoid Genotoxicity Manifesting as Transgenerational Teratogenesis, Cancerogenesis and Aging Acceleration

  2023cites this paper
• Cannabis Pharmacogenomics: A Path to Personalized Medicine

  2023cites this paper
• The use of polygenic risk scores as a covariate in psychological studies

  2022cites this paper
• Cannabis induced psychosis: a systematic review on the role of genetic polymorphisms.

  2022cites this paper
• Serum Proteomic Analysis of Cannabis Use Disorder in Male Patients

  2021cites this paper
• Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation

  2021cites this paper
• Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson’s Disease

  2021influential citation
• Cannabis, Schizophrenia Risk and Genetics: A Case Report of a Patient With Homozygous Valine Catechol-O-Methyltransferase Polymorphism

  2021cites this paper
• Cannabis and Psychosis: A Review of the Risk Factors Involved

  2020cites this paper
• Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?

  2020cites this paper
• Polygenic liability for schizophrenia and childhood adversity influences daily‐life emotion dysregulation and psychosis proneness

  2020cites this paper
• Factors Moderating the Association between Cannabis Use and Psychosis Risk: A Systematic Review

  2020cites this paper
• Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans

  2019cites this paper
• Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype.

  2019cites this paper
• Interaction between polygenic liability for schizophrenia and childhood adversity influences daily-life emotional dysregulation and psychosis proneness

  2019cites this paper
• Liprin alfa 2 gene expression is increased by cannabis use and associated with neuropsychological function.

  2019cites this paper
• Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis.

  2019cites this paper
• Terminology and assessment tools of psychosis: A systematic narrative review

  2019cites this paper
• Is Cannabis Harmless? Focus on Brain Function.

  2019cites this paper
• Cannabis Use Disorders

  2018cites this paper
• Cannabinoids and the Brain: The Effects of Endogenous and Exogenous Cannabinoids on Brain Systems and Function

  2018cites this paper
• The interaction between cannabis use and the Val158Met polymorphism of the COMT gene in psychosis: A transdiagnostic meta – analysis

  2018cites this paper
• Investigating the clinical correlates of violent behaviour in schizophrenia

  2018cites this paper
• The Association Between Cannabinoids and Psychosis

  2018cites this paper
• Pharmacogenetics of Cannabinoids

  2017cites this paper
• Do people with schizophrenia experience more negative emotion and less positive emotion in their daily lives? A meta-analysis of experience sampling studies.

  2017cites this paper
• Cannabis-Induced Psychosis: A Review

  2017cites this paper
• Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use

  2017cites this paper
• Cannabis and development of dual diagnoses: A literature review

  2017cites this paper
• The effect of interactions between genetics and cannabis use on neurocognition. A review

  2017cites this paper
• COMT Genotypes, Cannabis Use, and Psychosis: Gene-Environment Interaction Evidence from Human Populations, and Its Methodological Concerns

  2017cites this paper
• Interactions Between Variation in Candidate Genes and Environmental Factors in the Etiology of Schizophrenia and Bipolar Disorder: a Systematic Review

  2017cites this paper
• Predictors of psychosis risk and neurocognitive deficits

  2017cites this paper
• Genetic Influences in Cannabis Use Disorder and Psychosis: Dopamine and Beyond.

  2016cites this paper
• A treatise on secondary psychopathy: Psychobiological pathways to severe antisociality

  2016cites this paper
• The impact of genes by childhood adversity interaction on the clinical and social outcomes of psychosis

  2016cites this paper
• Biologist and Former Head of Health Education

  2016cites this paper
• Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.

  2016cites this paper
• COMT Val(158)Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions.

  2016cites this paper
• Ambulatory assessment as a means of longitudinal phenotypes characterization in psychiatric disorders.

  2016cites this paper
• The Trilogy of GxE: Conceptualization, Operationalization, and Application

  2016cites this paper
• Opioid-induced Hallucinations: A Review of the Literature, Pathophysiology, Diagnosis, and Treatment

  2016cites this paper
• Two hit’ neurodevelopmental mechanisms in schizophrenia: Focus on animal models and the role of BDNF

  2015cites this paper
• Cannabinoids and schizophrenia

  2015cites this paper
• Zooming into the micro-level of experience : an approach for understanding and treating psychopathology

  2015cites this paper
• Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids

  2015cites this paper
• Medical Marijuana: The State of the Science

  2015cites this paper
• The relationship between catechol-O-methyltransferase gene Val158Met (COMT) polymorphism and premorbid cannabis use in Turkish male patients with schizophrenia.

  2015cites this paper
• Genetic moderation of the effects of cannabis: Catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences

  2015influential citation
• The Relationship between Bipolar Disorder and Cannabis Use in Daily Life: An Experience Sampling Study

  2015influential citation
• Obstetric complications, genetic liability and psychosis : a study of Gene X Environment interaction

  2014cites this paper
• Nature-Nurture Integration

  2014cites this paper
• The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability

  2014cites this paper
• Gene × environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution.

  2014cites this paper
• Gone to Pot – A Review of the Association between Cannabis and Psychosis

  2014cites this paper
• The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research

  2014cites this paper
• Cannabis controversies: how genetics can inform the study of comorbidity.

  2014cites this paper
• Have the genetics of cannabis involvement gone to pot?

  2014cites this paper
• Epidemiological, neurobiological, and genetic clues to the mechanisms linking cannabis use to risk for nonaffective psychosis.

  2014cites this paper
• Molecular genetic gene-environment studies using candidate genes in schizophrenia: a systematic review.

  2013cites this paper
• Duration of untreated psychosis in adolescents: ethnic differences and clinical profiles.

  2013cites this paper
• Improving the reliability and reporting of genetic association studies.

  2013cites this paper
• Das Gen des metabotropen Glutamatrezeptors 8 und sein Einfluss auf die Schizophrenie.

  2013cites this paper
• Ambulatory assessment.

  2013cites this paper
• The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val¹⁵⁸Met polymorphism.

  2013cites this paper
• Predicting post-traumatic stress disorder in veterans: interaction of traumatic load with COMT gene variation.

  2013cites this paper
• Dose-response effect between cannabis use and psychosis liability in a non-clinical population: evidence from a snowball sample.

  2013cites this paper
• Relationship between the COMT-Val158Met and BDNF-Val66Met Polymorphisms, Childhood Trauma and Psychotic Experiences in an Adolescent General Population Sample

  2013cites this paper
• Genes, environment and their interplay in the development of psychopathological characteristics and their neuroimaging correlates in general population / Genes, ambiente y su interacción en el desarrollo de características psicopatológicas y sus correlatos de neuroimagen en poblaicón general

  2013cites this paper
• Does Higher Potency of Cannabis Mean Higher Risk for Psychosis

  2013cites this paper
• Cannabis and Psychosis: A Systematic Review of Genetic Studies

  2013cites this paper
• Understanding the suicidal mind : an ecological investigation of the differential activation hypothesis of suicidal relapse in first episode psychosis

  2013cites this paper
• Genes and environments in schizophrenia: The different pieces of a manifold puzzle.

  2013cites this paper
• Candidate Genes Involved in the Expression of Psychotic Symptoms: A Focus on Hallucinations

  2013cites this paper
• The role of catechol-O-methyltransferase in reward processing and addiction.

  2012cites this paper
• Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function

  2012cites this paper
• Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.

  2012cites this paper
• [Can cannabis use increase the risk for schizophrenic psychoses?].

  2012cites this paper
• Genetic variation underlying psychosis-inducing effects of cannabis: critical review and future directions.

  2012cites this paper
• Importance of COMT in the regulation of prefrontal dopamine

  2012cites this paper
• Cannabis use and psychosis: theme introduction.

  2012cites this paper
• Modelling the emergence of hallucinations: early acquired vulnerabilities, proximal life stressors and maladaptive psychological processes

  2012cites this paper
• Predicting risk and the emergence of schizophrenia.

  2012cites this paper
• Adolescent exposure to cannabis as a risk factor for psychiatric disorders

  2012cites this paper
• Epigenetic Epidemiology of Psychiatric Disorders

  2012cites this paper
• Change in delusions with treatment and the role of reasoning

  2012cites this paper
• Epigenetic epidemiology in psychiatry: A translational neuroscience perspective

  2012cites this paper
• Chapter 8 Does Higher Potency of Cannabis Mean Higher Risk for Psychosis

  2012cites this paper
• Kann Cannabis das Risiko für schizophrene Psychosen erhöhen?

  2012cites this paper
• A General Survey of its Harmful Effects Submission to The Social Justice Policy Group

  2012cites this paper
• Evidence that interactive effects of COMT and MTHFR moderate psychotic response to environmental stress

  2012cites this paper
• An investigation of the relationship between Bipolar Disorder and Cannabis use

  2011cites this paper
• Cannabis Use and Bipolar Disorder: Bipolar Disorder Case Identification and Cannabis Use Risk Assessment: A Dissertation

  2011cites this paper
• eview annabis use in young people : The risk for schizophrenia

  2011cites this paper
• Is cannabis responsible for early onset psychotic illnesses

  2011cites this paper
• Effects of cannabis use on age at onset in schizophrenia and bipolar disorder.

  2011cites this paper
• Critical Review of Gene-Environment Interactions in Psychiatry: Evidence Consistent with the Possibility of Publication Bias, Low Power, Multiple Testing, and Type I Errors in the Literature

  2011cites this paper
• Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia.

  2011cites this paper
• Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism

  2011cites this paper
• Summaries from the XVIII World Congress of Psychiatric Genetics, Athens, Greece, 3-7 October 2010.

  2011cites this paper